Neutrophil Elastase Inhibitor

Neutrophil Elastase Inhibitor Struktur
1448314-31-5
CAS-Nr.
1448314-31-5
Englisch Name:
Neutrophil Elastase Inhibitor
Synonyma:
Neutrophil Elastase Inhibitor;Neutrophil elastase inhibitor 1;1-(3-methylbenzoyl)indazole-3-carbonitrile;Neutrophil Elastase Inhibitor Exclusive;1H-Indazole-3-carbonitrile, 1-(3-methylbenzoyl)-
CBNumber:
CB53152699
Summenformel:
C16H11N3O
Molgewicht:
261.28
MOL-Datei:
1448314-31-5.mol

Neutrophil Elastase Inhibitor Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
≤0.5mg/ml in ethanol;10mg/ml in DMSO;30mg/ml in dimethyl formamide
Aggregatzustand
crystalline solid

Sicherheit

Neutrophil Elastase Inhibitor Chemische Eigenschaften,Einsatz,Produktion Methoden

Neutrophil Elastase Inhibitor Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Neutrophil Elastase Inhibitor Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 20)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9806 58
MQ (shanghai) Pharmaceuticals Co., Ltd. 13761635123
1014988033@qq.com China 4969 55
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11217 58
MedBioPharmaceutical Technology Inc 021-69568360 18916172912
order@med-bio.cn China 8140 58
Aikon International Limited 18626450290
yftan@aikonchem.com China 10715 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39953 58
Nanjing Tengyi Biotechnology Co., Ltd 025-58851786 17714337195
sales@tybiochem.com China 7413 58
Shaoguan Qicheng Biotechnology Co., Ltd 18122215013
780229652@qq.com China 1132 58
ApexBio Technology --
sales@apexbt.com United States 6251 58

  • Neutrophil Elastase Inhibitor
  • Neutrophil Elastase Inhibitor Exclusive
  • 1-(3-methylbenzoyl)indazole-3-carbonitrile
  • 1H-Indazole-3-carbonitrile, 1-(3-methylbenzoyl)-
  • Neutrophil elastase inhibitor 1
  • 1448314-31-5
Copyright 2019 © ChemicalBook. All rights reserved